Vai al contenuto principale della pagina

Nonclinical safety assessment [[electronic resource] ] : a guide to international pharmaceutical regulations / / edited by William J. Brock, Kenneth L. Hastings, Kathy M. McGown



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Titolo: Nonclinical safety assessment [[electronic resource] ] : a guide to international pharmaceutical regulations / / edited by William J. Brock, Kenneth L. Hastings, Kathy M. McGown Visualizza cluster
Pubblicazione: Chichester, West Sussex, : John Wiley & Sons, 2013
Descrizione fisica: 1 online resource (487 p.)
Disciplina: 615.1/901
Soggetto topico: Drug development - International cooperation
Drugs - Toxicology - International cooperation
Altri autori: BrockWilliam J  
HastingsKenneth L  
McGownKathy M  
Note generali: Description based upon print version of record.
Nota di bibliografia: Includes bibliographical references and index.
Nota di contenuto: Introduction to the development of drugs / Kathy McGown -- ICH / Ken Hastings -- USFDA / Bill Brock -- Latin America : MERCOSUR countries / Cristiana Leslie Corra -- Canada / Mark T. Goldberg -- EMEA / Adam Woolley -- Africa / Fariza Feraoun -- China / Lijie Fu -- Japan / Kazuichi Nakamura -- India / K.S. Rao -- Australia / Doug Francis -- Chronic repeat dose testing / Shana Azri-Meehan -- Carcinogenicity / James Popp -- Genotoxicity / Mark Powley -- Developmental and reproductive toxicology / Robert Parker -- Juvenile testing and pediatric claim / Melissa Tassinari -- Immunotoxicology / Leigh Ann Burns Naas -- Biologics / Chris Ellis -- Vaccines / Robert House -- Phototoxicity and photocarcinogenicity / Chris Sambuco -- Degradants, impurities excipients, and metabolites / Bob Osterberg.
Sommario/riassunto: Bringing a new drug to market is a costly time-consuming process. Increased regional and international regulation over the last twenty years, while necessary, has only served to amplify these costs. In response to this escalation, developmental strategies have shifted towards a more global approach. In order to create the most cost-effective and safe processes, it is critical for those bringing drugs to market to understand both the globally accepted regulations and the local variations. Nonclinical Safety Assessment: A Guide to International Pharmaceutical Regulations provides a practi
Titolo autorizzato: Nonclinical safety assessment  Visualizza cluster
ISBN: 1-118-51700-8
1-299-24266-9
1-118-51701-6
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910141613203321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui